To confirm the non-inferiority of the IOP-lowering effect of the 0.0015 % Tafluprost ophthalmic solution to the 0.005 % Latanoprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.Safety was also compared between two groups .